![](/img/cover-not-exists.png)
Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy
Scott B. Cantor, Linda S. Elting, David V. Hudson Jr., Edward B RubensteinVolume:
97
Year:
2003
Language:
english
Pages:
8
DOI:
10.1002/cncr.11447
File:
PDF, 315 KB
english, 2003